UCL Institute of Neurology
- IoN HOME
- About the Institute
- Study Here
- Research Departments
- Department of Brain Repair & Rehabilitation
- Department of Clinical and Experimental Epilepsy
- Department of Clinical Neuroscience
- Department of Molecular Neuroscience
- Department of Neurodegenerative Disease
- Department of Neuroinflammation
- Department Home
- Vacancies
- News
- Sources of support
- Publications
- Research themes
- Sobell Department of Motor Neuroscience and Movement Disorders
- Wellcome Department of Imaging Neuroscience
- Services & Library
- Vacancies and PhD Projects
- Contact Us
- National Hospital for Neurology and Neurosurgery
- Support Us
- IoN Intranet
- Department Home
- Vacancies
- News
- Sources of support
- Publications
-
Research themes
- Cell Signalling Laboratory
- Diagnosis, prognosis and therapeutic monitoring in MS
- Experimental neuroinflammation
- Magnetic resonance physics
- Mechanisms of disability and recovery in MS
- MRI & pathology in MS
- MS Clinical Trial Unit
- Neuroimmunology Unit
- Neuropsychiatry Group: Brain abnormalities in psychosis
- NeuroResource Tissue Bank
- NMR Research Unit
Sources of support
External organisations that have supported our research:
- Aims2Cure
- AstraZeneca
- Biogen Idec
- Bloomsbury Bioseed Fund
- BRT
- Celltech
- CRDC
- DeCode Genetics
- Eisai
- GlaxoSmithKline
- MRC
- Multiple Sclerosis Society of Great Britain and Northern Ireland
- Pfizer
- Pharmagene
- Progressive Supranuclear Palsy (PSP Europe) Association
- Research Advisory Board of St. Bartholomews and the London Hospital
- Schering AG
- Serono
- Sir Jules Thorn Charitable Trust
- Teva
- Wellcome Trust
